Denali Therapeutics Inc.
20.81
2.07 (11.05%)
At close: Jan 15, 2025, 12:42 PM

Ratios (Annual)

Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15
PE Ratio -20.3 -10.71 -18.65 128.31 -8.43 -52.8 -2.65 -1.59 -3.84
PS Ratio 8.92 32.19 111.38 27.19 62.43 14.82 n/a n/a n/a
PB Ratio 2.86 3.35 5.63 7.93 4.22 3.50 0.50 0.54 -4.12
P/FCF Ratio -7.95 -13.3 -24.65 22.10 -9.83 40.96 -2.94 -1.76 -3.56
P/OCF Ratio -8.23 -14.27 -25.64 21.93 -10.99 38.18 -3.05 -1.9 -4.28
OCF/S Ratio -1.08 -2.26 -4.34 1.24 -5.68 0.39 n/a n/a n/a
Debt / Equity Ratio 0.05 0.06 0.06 0.06 0.17 n/a n/a n/a n/a
Quick Ratio 13.65 3.78 2.37 20.86 9.48 14.93 28.95 19.98 9.60
Current Ratio 13.65 3.77 2.37 20.86 9.48 14.67 28.92 19.98 9.60
Asset Turnover 0.29 0.07 0.03 0.21 0.05 0.20 n/a n/a n/a
Interest Coverage n/a -23.06 n/a n/a -14.01 n/a -46.11 n/a -153.02
Return on Equity (ROE) -0.14 -0.31 -0.3 0.06 -0.5 -0.07 -0.19 -0.34 1.07
Return on Assets (ROA) -0.13 -0.22 -0.21 0.04 -0.36 -0.05 -0.18 -0.32 -0.46
Return on Capital (ROIC) -0.18 -0.31 -0.29 0.04 -0.42 -0.07 -0.19 -0.33 -0.5
Dividend Yield n/a n/a n/a n/a n/a n/a n/a n/a n/a
Payout Ratio n/a n/a n/a n/a n/a n/a n/a n/a n/a
Gross Profit Margin 94.94% 93.52% 88.47% 36.66% -624.87% 94.26% n/a n/a n/a
Net Profit Margin -43.94% -300.56% -597.15% 21.19% -740.74% -28.06% n/a n/a n/a
Pretax Profit Margin -43.93% -300.54% -598.34% 21.44% -742.05% -28.06% n/a n/a n/a
Operating Profit Margin -59.51% -314.16% -607.78% 18.69% -799.1% -35.9% n/a n/a n/a
FCF Margin -112.22% -242.06% -451.88% 123.06% -635.34% 36.17% n/a n/a n/a
EBITDA Margin -54.45% -304.58% -590.12% 18.69% -769.15% -30.16% n/a n/a n/a

Create Price Alert on DNLI

Your price alert will notify you when the stock price is above 20.81.

Add to Watchlist